Intranasal delivery of nanoparticle-based vaccine increases protection against S. pneumoniae

Corticotropin-releasing hormone receptor-1 and 2 activity produces divergent resistance against stress-induced pulmonary Streptococcus pneumoniae infection

(2011) Byung-Jin Kim et al.   JOURNAL OF NEUROIMMUNOLOGY

Toll-Like Receptor-7 Agonist Decoration Enhances the Adjuvanticity of Chitosan–DNA Nanoparticles

(2011) Simon Heuking et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice

(2011) A.I. Camacho et al.   VACCINE

Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis

(2011) Marie Ballester et al.   VACCINE

Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin

(2010) Marco Derudas et al.   BIOORGANIC & MEDICINAL CHEMISTRY

PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration

(2010) Armando Stano et al.   VACCINE

Mucosal perspectives in pneumococcal vaccine development: A meeting summary

(2009) Adam K.A. Wright   VACCINE